Relaxin family peptide receptor (RXFP1) coupling to Galphai3, involves the C-terminal Arg752 and localization within membrane raft microdomains

Michelle Louise Halls, Emma Therese van der Westhuizen, John D Wade, Bronwyn Anne Evans, Ross A D Bathgate, Roger James Summers

Research output: Contribution to journalArticleResearchpeer-review

Abstract

The relaxin family peptide receptors (RXFP) 1 and 2 are targets for the relaxin family peptides relaxin and insulin-like peptide 3 (INSL3) respectively. Although both receptors and peptides share a high degree of sequence identity, the cAMP signaling pathways activated by the two systems are quite distinct. Relaxin activation of RXFP1 initially results in accumulation of cAMP via Galphas but this is modulated by inhibition of cAMP through GalphaoB. With time, RXFP1 recruits coupling to Galphai3 causing additional cAMP accumulation via a Galphai3-Gbetagamma-PI3K-PKCzeta pathway. In contrast, INSL3 activation of RXFP2 results in accumulation of cAMP only via Galphas, modulated by cAMP inhibition through GalphaoB. Thus the aim of this study was to identify the cause of differential G-protein coupling between these highly similar receptors. Construction of chimeric receptors revealed that Galphai3 coupling is dependent upon the transmembrane region of RXFP1 and independent of the receptor ectodomain or ligand bound. Generation of C-terminal truncated receptors identified the terminal 10 amino acids of the RXFP1 C-terminus as essential for Galphai3 signaling, and point mutations revealed an obligatory role for Arg(752). RXFP1-mediated Galphai3, but not Galphas or GalphaoB, signaling was also found to be dependent upon membrane rafts, and RXFP1 coupled to Galphai3 after only 3 min of receptor stimulation. Therefore RXFP1 coupling to the Galphai3-Gbetagamma-PI3K-PKCzeta pathway requires the terminal 10 amino acids of the RXFP1 C-terminus and membrane raft localisation, and the observed delay in this pathway occurs downstream of Galphai3.
Original languageEnglish
Pages (from-to)415 - 428
Number of pages14
JournalMolecular Pharmacology
Volume75
Issue number2
DOIs
Publication statusPublished - 2009

Cite this

@article{c3610eded78a4a37b4b7aa90651e7dc9,
title = "Relaxin family peptide receptor (RXFP1) coupling to Galphai3, involves the C-terminal Arg752 and localization within membrane raft microdomains",
abstract = "The relaxin family peptide receptors (RXFP) 1 and 2 are targets for the relaxin family peptides relaxin and insulin-like peptide 3 (INSL3) respectively. Although both receptors and peptides share a high degree of sequence identity, the cAMP signaling pathways activated by the two systems are quite distinct. Relaxin activation of RXFP1 initially results in accumulation of cAMP via Galphas but this is modulated by inhibition of cAMP through GalphaoB. With time, RXFP1 recruits coupling to Galphai3 causing additional cAMP accumulation via a Galphai3-Gbetagamma-PI3K-PKCzeta pathway. In contrast, INSL3 activation of RXFP2 results in accumulation of cAMP only via Galphas, modulated by cAMP inhibition through GalphaoB. Thus the aim of this study was to identify the cause of differential G-protein coupling between these highly similar receptors. Construction of chimeric receptors revealed that Galphai3 coupling is dependent upon the transmembrane region of RXFP1 and independent of the receptor ectodomain or ligand bound. Generation of C-terminal truncated receptors identified the terminal 10 amino acids of the RXFP1 C-terminus as essential for Galphai3 signaling, and point mutations revealed an obligatory role for Arg(752). RXFP1-mediated Galphai3, but not Galphas or GalphaoB, signaling was also found to be dependent upon membrane rafts, and RXFP1 coupled to Galphai3 after only 3 min of receptor stimulation. Therefore RXFP1 coupling to the Galphai3-Gbetagamma-PI3K-PKCzeta pathway requires the terminal 10 amino acids of the RXFP1 C-terminus and membrane raft localisation, and the observed delay in this pathway occurs downstream of Galphai3.",
author = "Halls, {Michelle Louise} and {van der Westhuizen}, {Emma Therese} and Wade, {John D} and Evans, {Bronwyn Anne} and Bathgate, {Ross A D} and Summers, {Roger James}",
year = "2009",
doi = "10.1124/mol.108.051227",
language = "English",
volume = "75",
pages = "415 -- 428",
journal = "Molecular Pharmacology",
issn = "1521-0111",
publisher = "ACS Books",
number = "2",

}

Relaxin family peptide receptor (RXFP1) coupling to Galphai3, involves the C-terminal Arg752 and localization within membrane raft microdomains. / Halls, Michelle Louise; van der Westhuizen, Emma Therese; Wade, John D; Evans, Bronwyn Anne; Bathgate, Ross A D; Summers, Roger James.

In: Molecular Pharmacology, Vol. 75, No. 2, 2009, p. 415 - 428.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Relaxin family peptide receptor (RXFP1) coupling to Galphai3, involves the C-terminal Arg752 and localization within membrane raft microdomains

AU - Halls, Michelle Louise

AU - van der Westhuizen, Emma Therese

AU - Wade, John D

AU - Evans, Bronwyn Anne

AU - Bathgate, Ross A D

AU - Summers, Roger James

PY - 2009

Y1 - 2009

N2 - The relaxin family peptide receptors (RXFP) 1 and 2 are targets for the relaxin family peptides relaxin and insulin-like peptide 3 (INSL3) respectively. Although both receptors and peptides share a high degree of sequence identity, the cAMP signaling pathways activated by the two systems are quite distinct. Relaxin activation of RXFP1 initially results in accumulation of cAMP via Galphas but this is modulated by inhibition of cAMP through GalphaoB. With time, RXFP1 recruits coupling to Galphai3 causing additional cAMP accumulation via a Galphai3-Gbetagamma-PI3K-PKCzeta pathway. In contrast, INSL3 activation of RXFP2 results in accumulation of cAMP only via Galphas, modulated by cAMP inhibition through GalphaoB. Thus the aim of this study was to identify the cause of differential G-protein coupling between these highly similar receptors. Construction of chimeric receptors revealed that Galphai3 coupling is dependent upon the transmembrane region of RXFP1 and independent of the receptor ectodomain or ligand bound. Generation of C-terminal truncated receptors identified the terminal 10 amino acids of the RXFP1 C-terminus as essential for Galphai3 signaling, and point mutations revealed an obligatory role for Arg(752). RXFP1-mediated Galphai3, but not Galphas or GalphaoB, signaling was also found to be dependent upon membrane rafts, and RXFP1 coupled to Galphai3 after only 3 min of receptor stimulation. Therefore RXFP1 coupling to the Galphai3-Gbetagamma-PI3K-PKCzeta pathway requires the terminal 10 amino acids of the RXFP1 C-terminus and membrane raft localisation, and the observed delay in this pathway occurs downstream of Galphai3.

AB - The relaxin family peptide receptors (RXFP) 1 and 2 are targets for the relaxin family peptides relaxin and insulin-like peptide 3 (INSL3) respectively. Although both receptors and peptides share a high degree of sequence identity, the cAMP signaling pathways activated by the two systems are quite distinct. Relaxin activation of RXFP1 initially results in accumulation of cAMP via Galphas but this is modulated by inhibition of cAMP through GalphaoB. With time, RXFP1 recruits coupling to Galphai3 causing additional cAMP accumulation via a Galphai3-Gbetagamma-PI3K-PKCzeta pathway. In contrast, INSL3 activation of RXFP2 results in accumulation of cAMP only via Galphas, modulated by cAMP inhibition through GalphaoB. Thus the aim of this study was to identify the cause of differential G-protein coupling between these highly similar receptors. Construction of chimeric receptors revealed that Galphai3 coupling is dependent upon the transmembrane region of RXFP1 and independent of the receptor ectodomain or ligand bound. Generation of C-terminal truncated receptors identified the terminal 10 amino acids of the RXFP1 C-terminus as essential for Galphai3 signaling, and point mutations revealed an obligatory role for Arg(752). RXFP1-mediated Galphai3, but not Galphas or GalphaoB, signaling was also found to be dependent upon membrane rafts, and RXFP1 coupled to Galphai3 after only 3 min of receptor stimulation. Therefore RXFP1 coupling to the Galphai3-Gbetagamma-PI3K-PKCzeta pathway requires the terminal 10 amino acids of the RXFP1 C-terminus and membrane raft localisation, and the observed delay in this pathway occurs downstream of Galphai3.

UR - http://www.scopus.com/record/display.url?eid=2-s2.0-59449108031&origin=inward&txGid=DTKScozabqgfK1PehPws7cv%3a2

U2 - 10.1124/mol.108.051227

DO - 10.1124/mol.108.051227

M3 - Article

VL - 75

SP - 415

EP - 428

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 1521-0111

IS - 2

ER -